Companies › ZVRA
ZEVRA THERAPEUTICS INC (ZVRA)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001434647 · EDGAR filings · Updated 2026-07-08
ZEVRA THERAPEUTICS INC (ZVRA) has reported institutional ownership of 70.4%, with 148 institutional managers holding positions valued at $384.5M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-08 — Notice of proposed sale filed (Form 144)
- 2026-06-23 — Insider transaction reported (Form 4)
- 2026-06-18 — Insider transaction reported (Form 4)
- 2026-06-18 — Insider transaction reported (Form 4)
- 2026-06-18 — Insider transaction reported (Form 4)
- 2026-06-18 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ZEVRA THERAPEUTICS INC has 148 institutional holders and institutional ownership of 70.4%.
Insider activity
Insiders reported 27 transactions (3 buys, 10 sells) across 9 reporting insiders, with a net reported value of −$1.43M.
Data flags from SEC filings
Related companies
DESIGN THERAPEUTICS INC (DSGN) · LARIMAR THERAPEUTICS INC (LRMR) · ZURA BIO LTD (ZURA) · ENGENE HOLDINGS INC (ENGN) · CRYOPORT INC (CYRX) · ABSCI CORPORATION (ABSI)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-08.